Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span
Open accessThe DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Abstract
Little is known about the relative importance of monocyte and tissue-resident macrophages in the development of lung fibrosis. We show that specific genetic deletion of monocyte-derived alveolar macrophages after their recruitment to the lung ameliorated lung fibrosis, whereas tissue-resident alveolar macrophages did not contribute to fibrosis. Using transcriptomic profiling of flow-sorted cells, we found that monocyte to alveolar macrophage differentiation unfolds continuously over the course of fibrosis and its resolution. During the fibrotic phase, monocyte-derived alveolar macrophages differ significantly from tissue-resident alveolar macrophages in their expression of profibrotic genes. A population of monocyte-derived alveolar macrophages persisted in the lung for one year after the resolution of fibrosis, where they became increasingly similar to tissue-resident alveolar macrophages. Human homologues of profibrotic genes expressed by mouse monocyte-derived alveolar macrophages during fibrosis were up-regulated in human alveolar macrophages from fibrotic compared with normal lungs. Our findings suggest that selectively targeting alveolar macrophage differentiation within the lung may ameliorate fibrosis without the adverse consequences associated with global monocyte or tissue-resident alveolar macrophage depletion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent studies suggest that the latter effect is at least in part due to the contribution of pro-fibrotic macrophages to the activation of fibroblasts into to myofibroblasts in a process that depends on physical contact (14, 15).”
From Modeling mechanical activation of macrophages during pulmonary fibrogenesis for targeted anti-fibrosis therapy (2024) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Following tissue injury, many resident macrophages die, and the lung parenchyma initiates an innate immune response characterized by the differentiation of bone marrow-derived monocytes to supplement the macrophage pool 61.”
From Nicotinamide phosphoribosyltransferase prompts bleomycin-induced pulmonary fibrosis by driving macrophage M2 polarization in mice (2024) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The pathogenic role of Mo-AMs in lung fibrosis has been largely attributed to their activity in producing a number of pro-fibrotic mediators, such as TGF-β, PDGF-α, osteopontin (OPN), and MMPs1,3,11,13,15,18,28.”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [1]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“depletion of Mo-AMs via several strategies conferred protection from lung fibrosis in multiple mouse models1,3,10,11,13,20”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“Mo-AMs, but not TR-AMs, are responsible for the pro-fibrotic activity of this group of cells1,3,10,13”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [1]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364 · cited 2×
“, 2013), and differential gene expression was assessed using edgeR (Robinson et al., 2010; McCarthy et al., 2012) R/Bioconductor packages.”
MethodMacrophage activation and polarization: nomenclature and experimental guidelines
Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.008 · Cited by 6,337
McCarthy, D. J., Chen, Y., & Smyth, G. K. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks042 · Cited by 5,195 · cited 2×
“, 2013), and differential gene expression was assessed using edgeR (Robinson et al., 2010; McCarthy et al., 2012) R/Bioconductor packages.”
MethodThe M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689 · cited 1×
“Macrophage polarization refers to distinct sets of inflammatory (M1) or fibrotic (M2) genes that are expressed by macrophages in cell culture that are first induced toward differentiation and then treated with LPS and IFN-γ or IL-4, respectively (Martinez and Gordon, 2014; Murray et al., 2014).”
BackgroundMacrophages in Tissue Repair, Regeneration, and Fibrosis
Wynn, T. A., & Vannella, K. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.015 · Cited by 4,481
Software for Computing and Annotating Genomic Ranges
Lawrence, M., Huber, W., Pagès, H., Aboyoun, P., Carlson, M., Gentleman, R., Morgan, M. T., & Carey, V. J. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003118 · Cited by 4,398 · cited 3×
“…using FastQC, reads were trimmed and aligned to mm10 reference genome using TopHat2, read counts were associated with genes using the GenomicRanges (Lawrence et al., 2013), and differential gene expression was assessed using edgeR (Robinson et al., 2010; McCarthy et al., 2012) R/Bioconductor…”
MethodInfluentialGOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists
Eden, E., Navon, R., Steinfeld, I., Lipson, D., & Yakhini, Z. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-48 · Cited by 3,356
Fate Mapping Reveals Origins and Dynamics of Monocytes and Tissue Macrophages under Homeostasis
Yona, S., Kim, K.-W., Wolf, Y., Mildner, A., Varol, D., Breker, M., Strauss-Ayali, D., Viukov, S., Guilliams, M., Misharin, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.12.001 · Cited by 3,245 · cited 2×
“2387 IntroductIon Van Furth and colleagues suggested an adult monocytic origin of all macrophages, but it is now clear that many tissue-resident macrophages, including alveolar macrophages in the lung, are self-renewing populations that arise from fetal progenitors and require minimal input from circuiting adult monoc…”
BackgroundSelf-citationHashimoto, D., Chow, A., Noizat, C., Teo, P., Beasley, M. B., Leboeuf, M., Becker, C. D., See, P., Price, J., Lucas, D., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.004 · Cited by 2,311 · cited 3×
“Extending the findings from several groups (Guilliams et al., 2013; Hashimoto et al., 2013; van de Laar et al., 2016), we found that TR-AMs were remarkably stable, constituting >95% of alveolar macrophages at 14 mo of age (Fig.”
BackgroundTranscriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation
Xue, J., Schmidt, S. V., Sander, J., Draffehn, A., Krebs, W., Quester, I., De Nardo, D., Gohel, T. D., Emde, M., Schmidleithner, L., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.006 · Cited by 2,210 · cited 1×
“This “macrophage polarization” model is based on limited evidence and is conceptually incomplete (Xue et al., 2014; Nahrendorf and Swirski, 2016).”
Background
Cited by
Items 401–500 of 998
Inhibition of AXL ameliorates pulmonary fibrosis via attenuation of M2 macrophage polarisation
Kim, D. H., Kim, H. C., Im, K., Baek, I.-J., Choi, Y. J., Lee, H., Kim, D.-S., Lee, C. W., Jeong, J., Ban, K., et al. (2025) · European Respiratory Journal · doi:10.1183/13993003.00615-2024 · Cited by 33
“Several reports have suggested that monocyte-derived alveolar macrophages (Mo-AMs) are associated with pulmonary fibrosis (PF) [7, 8].”
An aging bone marrow exacerbates lung fibrosis by fueling profibrotic macrophage persistence
Farhat, A., Radhouani, M., Deckert, F., Zahalka, S., Pimenov, L., Fokina, A., Hakobyan, A., Oberndorfer, F., Brösamlen, J., Hladik, A., et al. (2025) · Science Immunology · doi:10.1126/sciimmunol.adk5041 · Cited by 38
Bibaki, E., Tsitoura, E., Vasarmidi, E., Margaritopoulos, G., Trachalaki, A., Koutoulaki, C., Georgopoulou, T., Spandidos, D., Tzanakis, N., & Antoniou, K. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8778 · Cited by 29
“In IPF alveolar macrophages deriving from monocytes recruited to the injured lungs are actively involved in the fibrotic process (51).”
BackgroundMacrophages and cadherins in fibrosis and systemic sclerosis
To, S., & Agarwal, S. K. (2019) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000657 · Cited by 32
Akbarpour, M., Lecuona, E., Chiu, S. F., Wu, Q., Querrey, M., Fernandez, R., Nunez-Santana, F., Sun, H., Ravi, S., Kurihara, C., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci135838 · Cited by 33
“obtained and murine lung cell staining performed as previously described (32, 55).”
MethodSelf-citationCheresh, P., Kim, S.-J., Huang, L. S., Watanabe, S., Joshi, N., Williams, K. J. N., Chi, M., Lu, Z., Harijith, A. K., Yeldandi, A. V., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165595 · Cited by 30
“Ex-Taq (Takara, Mountain View, CA, USA) was used for PCR, with specific primers to amplify a mitochondrial genomic in both short and long-form nuclear DNA (beta-globin) [8,12].”
MethodSelf-citationThe versatile biochemistry of iron in macrophage effector functions
Behmoaras, J. V. (2020) · FEBS Journal · doi:10.1111/febs.15682 · Cited by 32
Saku, A., Fujisawa, T., Nishimoto, K., Yoshimura, K., Hozumi, H., Karayama, M., Suzuki, Y., Furuhashi, K., Enomoto, N., Nakamura, Y., et al. (2021) · Respiratory Medicine · doi:10.1016/j.rmed.2021.106420 · Cited by 29
Inhibition of CHIT1 as a novel therapeutic approach in idiopathic pulmonary fibrosis
Sklepkiewicz, P. L., Dymek, B., Mlącki, M., Koralewski, R., Mazur, M., Nejman‐Gryz, P., Korur, S., Zagożdżon, A., Rymaszewska, A., von der Thüsen, J. H., et al. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174792 · Cited by 28
Querrey, M., Chiu, S. F., Lecuona, E., Wu, Q., Sun, H., Anderson, M. L., Kelly, M. E., Ravi, S., Misharin, A. V., Kreisel, D., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci157262 · Cited by 29
Self-citationLung Cell Atlases in Health and Disease
Adams, T. S., Marlier, A., & Kaminski, N. (2022) · Annual Review of Physiology · doi:10.1146/annurev-physiol-032922-082826 · Cited by 37
Graf, J., Trautmann-Rodriguez, M., Sabnis, S., Kloxin, A. M., & Fromen, C. A. (2023) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2023.106596 · Cited by 31
Warheit-Niemi, H. I., Hult, E. M., & Moore, B. B. (2019) · Clinical & Translational Immunology · doi:10.1002/cti2.1065 · Cited by 32
“Of note are recent findings identifying direct interactions between macrophages and myofibroblasts via cadherin-11, which possibly mediate the Mo-AM localisation to the profibrotic niche,(63) and importantly, specific deletion of MoAMs was found to ameliorate fibrosis.(55,56) These findings are further supported in hu…”
BackgroundResultInfluentialGu, X., Kang, H., Cao, S., Tong, Z., & Song, N. (2025) · Translational Research · doi:10.1016/j.trsl.2024.10.002 · Cited by 28
He, Y., Yang, F., Yang, L., Yuan, H., You, Y., Chen, Y., Wu, X., Min, H., Chen, J., & Li, C. R. (2024) · Nature Communications · doi:10.1038/s41467-024-54174-5 · Cited by 35
The ageing immune system as a driver of systemic ageing
Jang, I. H., Niedernhofer, L. J., Robbins, P. D., & Camell, C. D. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-026-01269-3 · Cited by 45
“Recruited monocyte-derived, but not tissue-resident, alveolar macrophages, contribute to lung fibrosis and persist even after resolution 150 .”
Balta, M. G., Papathanasiou, E., & CHRISTOPOULOS, P. F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.632238 · Cited by 30
“Moreover, a population of these infiltrated monocyte-derived macrophages may be associated with the pulmonary fibrosis (57, 58), also found in progressed COVID-19 cases.”
BackgroundA Novel Role of Nogo Proteins: Regulating Macrophages in Inflammatory Disease
Zhang, N., Cui, Y., Li, Y., & Mi, Y. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01124-0 · Cited by 32
Control of Tissue Fibrosis by 5-Methoxytryptophan, an Innate Anti-Inflammatory Metabolite
Wu, K. K. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.759199 · Cited by 31
“A number of signaling pathways including p38 MAPK (Ma et al., 1999; Stambe et al., 2004; Molkentin et al., 2017; Turner and Blythe, 2019), TGFβ/SMAD3 (Fang et al., 2020), PI3K/AKT (Zhang et al., 2016; Hsu et al., 2017; Fang et al., 2020; Hu et al., 2020); JNK (Grynberg et al., 2017) and STAT3…”
BackgroundIL10 trains macrophage profibrotic function after lung injury
Bhattacharyya, A., Boostanpour, K., Bouzidi, M. S., Magee, L., Chen, T. Y., Wolters, R. M., Torre, P., Pillai, S. K., & Bhattacharya, M. (2022) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00458.2021 · Cited by 33
Qin, W., Spek, C. A., Scicluna, B. P., van der Poll, T., & Duitman, J. (2022) · Respiratory Research · doi:10.1186/s12931-022-02088-5 · Cited by 33
“It has been shown that recruitment of monocytes contributes to macrophage populations during the development of pulmonary fibrosis [26, 34].”
BackgroundMethodInfluentialThe Impact of the Cancer Microenvironment on Macrophage Phenotypes
Ham, S., Lima, L. G., Lek, E. S. H., & Möller, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01308 · Cited by 30
“However, several studies show distinguishing features of monocyte-derived and tissue-resident macrophages in tissues (2, 57).”
BackgroundPGF2α signaling drives fibrotic remodeling and fibroblast population dynamics in mice
Rodríguez, L. R., Tang, S. Y., Barboza, W. R., Murthy, A., Tomer, Y., Cai, T., Iyer, S., Chavez, K., Das, U. S., Ghosh, S., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.172977 · Cited by 29
“Immune populations were identified by forward and side scatter followed by doublet discrimination of CD45 + viable cells and a sorting strategy modified from Misharin, et al. (55).”
MethodWang, J., & Chao, J. (2025) · Pharmaceuticals · doi:10.3390/ph18060812 · Cited by 32
“Multiplexed CODEX imaging reveals enrichment of M2-polarized macrophages at fibrotic lesions, where they suppress AT2 cell regeneration via the PD-1/PD-L1 axis and secrete IL-13 to activate fibroblasts and promote collagen deposition [2,125,126].”
Double-edged mitophagy: balancing inflammation and resolution in lung disease
Tian, S., Zhang, Y., Liu, C. X., Zhang, H., Lu, Q., Zhao, Y., & Fan, H. (2025) · Clinical Science · doi:10.1042/cs20256705 · Cited by 40
“M2 macrophages activate and proliferate fibroblasts, advancing PF [67].”
Nieto, C., Bragado, R., Municio, C., Sierra‐Filardi, E., Alonso, B., Escribese, M. M., Domínguez‐Andrés, J., Ardavín, C., Castrillo, A., Vega, M. A., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00031 · Cited by 31
“In the specific case of lung inflammation, monocyte-derived mouse A-MØ are the major drivers of fibrosis and become similar to tissue-resident A-MØ over time (44).”
BackgroundLung Macrophages: Multifunctional Regulator Cells for Metastatic Cells
Mukaida, N., Nosaka, T., Nakamoto, Y., & Baba, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010116 · Cited by 29
Allawzi, A. M., McDermott, I., Delaney, C. A., Nguyen, K. M., Banimostafa, L., Trumpie, A., Hernandez‐Lagunas, L., Riemondy, K. A., Gillen, A. E., Hesselberth, J. R., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201901038rr · Cited by 29
“Because inflammation is a known driver of fibrosis, we speculate that these protective effects on alveolar inflammation protect against lung fibrosis (9, 13, 14).”
BackgroundImmunophenotyping monocytes, macrophages and granulocytes in the Pteropodid bat Eonycteris spelaea
Gamage, A. M., Zhu, F., Ahn, M., Foo, R., Hey, Y. Y., Low, D. H. W., Mendenhall, I. H., Dutertre, C., & Wang, L. (2020) · Scientific Reports · doi:10.1038/s41598-019-57212-1 · Cited by 28
Venosa, A., Cowman, S. J., Katzen, J. B., Tomer, Y., Armstrong, B. S., Mulugeta, S., & Beers, M. F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.665818 · Cited by 33
The Gene Signature of Activated M-CSF-Primed Human Monocyte-Derived Macrophages Is IL-10-Dependent
Cuevas, V. D., Simón‐Fuentes, M., Orta‐Zavalza, E., Samaniego, R., Sánchez‐Mateos, P., Escribese, M. M., Cimas, F. J., Bustos, M., Pérez‐Diego, M., Ocaña, A., et al. (2021) · Journal of Innate Immunity · doi:10.1159/000519305 · Cited by 32
Qi, Y., Zhao, T., Li, R., & Han, M. (2022) · BioMed Research International · doi:10.1155/2022/9895504 · Cited by 28
“Lung fi brosis can be induced by monocyte-derived macrophages [18, 56].”
Plasticity towards Rigidity: A Macrophage Conundrum in Pulmonary Fibrosis
Sari, E., He, C., & Margaroli, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911443 · Cited by 29
“Some studies show that blockade of the recruitment of the monocyte-derived macrophages in the fibrotic niche might attenuate the fibrotic processes [54,177,178].”
BackgroundHan, W., Tanjore, H., Liu, Y., Hunt, R. P., Gutor, S. S., Serezani, A. P. M., & Blackwell, T. S. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200694 · Cited by 28
Biomaterial-assisted macrophage cell therapy for regenerative medicine
Sung, S., Steele, L. A., Risser, G. E., & Spiller, K. L. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114979 · Cited by 28
Cheng, D., Lian, W., Wang, T., Xi, S., Jia, X., Li, Z., Xiong, H., Wang, Y., Sun, W., Zhou, S., et al. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.133713 · Cited by 29
Journey of monocytes and macrophages upon influenza A virus infection
Ruscitti, C., Radermecker, C., & Marichal, T. (2024) · Current Opinion in Virology · doi:10.1016/j.coviro.2024.101409 · Cited by 32
Auld, S. C., Sheshadri, A., Alexander‐Brett, J. M., Aschner, Y., Barczak, A. K., Basil, M. C., Cohen, K. A., Cruz, C. S. D., McGroder, C. F., Restrepo, M. I., et al. (2024) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202406-651st · Cited by 29
“…leads to an expansion of monocyte-derived interstitial macrophages (37) and alveolar macrophages (MoAMs) (38 – 41), which come into direct contact with fi broblasts in the matrix as they enter the alveolar space (39, 41 – 51) and express factors necessary for fi broblast proliferation (41, 44, 52).”
Self-citationMouse and human macrophages and their roles in cardiovascular health and disease
Gallerand, A., Han, J., Ivanov, S., & Randolph, G. J. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00580-3 · Cited by 29
Liu, L., Wu, P., Wei, Y., Lu, M., Ge, H., Wang, P., Sun, J., Horng, T., Liu, X., Shen, X., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2024.115220 · Cited by 33
Hoffman, E. T., Shah, A., Barboza, W. R., Rodríguez, L. R., Dherwani, R., Dooley, P. E., Minakin, K., Tomer, Y., Ayers, L. J., Jones, D. L., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63735-1 · Cited by 48
PARP1 Hinders Histone H2B Occupancy at the NFATc1 Promoter to Restrain Osteoclast Differentiation
Wang, C., Xiao, J., Nowak, K., Gunasekera, K., Alippe, Y., Speckman, S., Yang, T., Kress, D., Abu‐Amer, Y., Hottiger, M. O., et al. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3927 · Cited by 26
Carter, C. L., Parker, G. A., Hankey, K. G., Farese, A. M., MacVittie, T. J., & Kane, M. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-68508-y · Cited by 25
Fastrès, A., Pirottin, D., Fiévez, L., Tutunaru, A.-C., Bolen, G., Merveille, A., Marichal, T., Desmet, C. J., Bureau, F., & Clercx, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.611749 · Cited by 30
“December 2020 | Volume 11 | Article 611749 with results obtained in this study and suggests that recently recruited macrophages (clusters M1 and M2) have greater fibrotic capacity than mature AMs (clusters M0 and M3).”
BackgroundInfluentialAge-Related Dynamics of Lung-Resident Memory CD8+ T Cells in the Age of COVID-19
Goplen, N. P., Cheon, I. S., & Sun, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.636118 · Cited by 24
“Infiltrating monocyte-derived macrophages have been shown to exacerbate collagen-deposition following influenza infection (106).”
BackgroundInterpreting Immunoregulation in Lung Fibrosis: A New Branch of the Immune Model
Huaux, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.690375 · Cited by 31
“Recent data at single cell level suggest that pro-fibrotic macrophages did not demonstrate a shaped and clear M2-like polarization but resemble to alveolar macrophages deriving from monocytes (103).”
BackgroundWarheit-Niemi, H. I., Huizinga, G. P., Edwards, S. J., Wang, Y., Murray, S., O’Dwyer, D. N., & Moore, B. B. (2022) · ImmunoHorizons · doi:10.4049/immunohorizons.2200083 · Cited by 29
“Studies have identified macrophage subsets contributing to the development of fibrosis (50, 51), and it is possible that these macrophage populations drive the increased Cxcl2 expression and neutrophil recruitment.”
UGRP1-modulated MARCO+ alveolar macrophages contribute to age-related lung fibrosis
Chen, Y., Hao, X., Li, M., Tian, Z., & Cheng, M. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00338-8 · Cited by 27
Tseng, C., Sung, Y.-W., Chen, K., Wang, P.-Y., Yen, C., Sung, W., Wu, C., Ou, T., Tsai, W., Liao, W., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241511995 · Cited by 28
“Macrophages in lung tissue samples from patients with fibrosis are higher compared to controls without fibrosis [33].”
BackgroundSelf-citationCorleis, B., Tzouanas, C. N., Wadsworth, M. H., Cho, J. L., Linder, A. H., Schiff, A. E., Zessin, B., Stei, F., Dorhoi, A., Dickey, A. K., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adg3451 · Cited by 30
Wu, W., Jia, H., Chen, S., Ma, X., Zhou, S. F., Qiu, L., Wu, X., Li, P., Chu, H., & Zhang, G. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00843-6 · Cited by 25
“It was notable that fibroblast activation and proliferation is caused by activated M2 macrophages which produce profibrotic factor TGF-β to facilitate the secretion of collagen and extracellular matrix proteins and thereby contributing to pulmonary fibrosis (Misharin et al. 2017).”
BackgroundWang, J., Peng, X., Yuan, N., Wang, B., Chen, S., Wang, B., & Xie, L. (2024) · Translational research · doi:10.1016/j.trsl.2024.05.012 · Cited by 31
Multiomic analysis of monocyte-derived alveolar macrophages in idiopathic pulmonary fibrosis
Zhang, M., Zhang, J., Hu, H., Zhou, Y., Lin, Z., Jing, H., & Sun, B. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05398-y · Cited by 33
“Also, APOE was found to be upregulated in alveolar macrophages in patients with IPF and played an important role in Collagen I phagocytosis [33, 55].”
BackgroundWang, S. F., Li, J., Wu, C., Lei, Z., Wang, T., Huang, X., Zhang, S., Liu, Y., Bi, X., Zheng, F., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111669 · Cited by 33
Ζαννίκου, Μ., Barbayianni, I., Fanidis, D., Grigorakaki, T., Vlachopoulou, E., Konstantopoulos, D., Fousteri, M. I., Nikitopoulou, I., Kotanidou, Α., Kaffe, E., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000862 · Cited by 23
Targeting Chitinase 1 and Chitinase 3-Like 1 as Novel Therapeutic Strategy of Pulmonary Fibrosis
Lee, S., Lee, C.-M., Ma, B., Kamle, S., Elias, J. A., Zhou, Y., & Lee, C. G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.826471 · Cited by 31
“Recent in vivo single cell and bulk RNA sequencing analysis revealed impressive phenotype changes in the development of profibrotic macrophages from the circulating monocytes to interstitial and resident alveolar macrophages according to the progress of fibrosis (Misharin et al., 2017; Aran et al., 2019; Ayaub et al.,…”
BackgroundScur, M., Mahmoud, A. B., Dey, S., Abdalbarri, F., Stylianides, I., Medina-Luna, D., Gamage, G. S., Woblistin, A., Wilson, A., Zein, H. S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34935-w · Cited by 27
Libório‐Ramos, S., Barbosa-Matos, C., Fernandes, R., Borges-Pereira, C., & Costa, S. (2023) · Cells · doi:10.3390/cells12030402 · Cited by 28
Min, B., Grant-Orser, A., & Johannson, K. A. (2023) · European Respiratory Review · doi:10.1183/16000617.0072-2023 · Cited by 26
Testicular immune cells and vasculature in Klinefelter syndrome from childhood up to adulthood
Willems, M., Vloeberghs, V., Gies, I., Schepper, J. D., Tournaye, H. J., Goossens, E., & Saen, D. V. (2020) · Human Reproduction · doi:10.1093/humrep/deaa132 · Cited by 27
Joglekar, M. M., Nizamoglu, M., Fan, Y., Nemani, S. S. P., Weckmann, M., Pouwels, S. D., Heijink, I. H., Melgert, B. N., Pillay, J., & Burgess, J. K. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.995051 · Cited by 27
“In mice, monocytes arriving in fibrotic lung tissue transform to macrophages to repopulate lung tissue and remain in the tissue with higher profibrotic activity compared to tissue-resident macrophages (Misharin et al., 2017).”
BackgroundKwak, D., Bradley, P. B., Subbotina, N., Ling, S., Teitz‐Tennenbaum, S., Osterholzer, J. J., Sisson, T. H., & Kim, K. K. (2023) · Respiratory Research · doi:10.1186/s12931-023-02629-6 · Cited by 25
Guttenberg, M. A., Vose, A. T., Birukova, A., Lewars, K., Cumming, R. I., Albright, M. C., Mark, J. I., Salazar, C. J., Swaminathan, S., Yu, Z., et al. (2024) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2023-0390oc · Cited by 32
Self-citationReinecke, J. B., Garcia, L. J., Gross, A. C., Cam, M., Cannon, M. V., Gust, M. J., Sheridan, J. P., Gryder, B. E., Dries, R., & Roberts, R. D. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-0049 · Cited by 30
“In the early wound-healing response, macrophages are predominantly inflammatory in nature (39, 40), marked by a high expression of antigen presentation proteins and inflammatory cytokines in the early phases of wound healing (41).”
Elewa, Y. H. A., Ichii, O., Takada, K., Nakamura, T., Masum, M. A., & Kon, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00271 · Cited by 23
“However, TR-AMs did not have role in fibrosis development (41).”
BackgroundThe role of macrophages in pulmonary hypertension: Pathogenesis and targeting
Chen, S., Yan, D., & Qiu, A. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106934 · Cited by 27
Bohaud, C., Johansen, M. D., Jørgensen, C., Kremer, L., Ipseiz, N., & Djouad, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.707856 · Cited by 29
Mukherjee, A., Epperly, M. W., Fisher, R., HOU, W., Shields, D. S., Wang, H., Greenberger, J. S., & Ortiz, L. A. (2021) · In Vivo · doi:10.21873/invivo.12601 · Cited by 25
Maladaptive TGF-β Signals to the Alveolar Epithelium Drive Fibrosis after COVID-19 Infection
Yao, C., Parimon, T., Espíndola, M. S., Hohmann, M. S., Konda, B. M., Hogaboam, C. M., Stripp, B. R., & Chen, P. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202302-0264le · Cited by 21
“Monocyte-derived macrophages are profibrotic and a key source of the TGF-b that drives lung fibrosis (9, 10).”
Fibrosis: Shared Lessons From the Lens and Cornea
Menko, A. S., Walker, J. L., & Stepp, M. A. (2019) · The Anatomical Record · doi:10.1002/ar.24088 · Cited by 26
“Similar results have been obtained studying lung fibrosis (Misharin et al., 2017).”
ResultLocation or origin? What is critical for macrophage propagation of lung fibrosis?
Zhou, X., & Moore, B. B. (2018) · European Respiratory Journal · doi:10.1183/13993003.00103-2018 · Cited by 25
Pommerolle, L., Beltramo, G., Biziorek, L., Truchi, M., Dias, A. M. M., Dondaine, L., Tanguy, J., Pernet, N., Gonçalves, V., Bouchard, A., et al. (2024) · Thorax · doi:10.1136/thorax-2023-221168 · Cited by 25
“22 Our study highlights the kinetic of Mo-AMs polarisation/recruitment in the lungs after BLM challenge.”
Iron-laden macrophage-mediated paracrine profibrotic signaling induces lung fibroblast activation
Li, Y., Du, X., Hu, Y., Wang, D., Duan, L., Zhang, H., Zhang, R., Xu, Y., Zhou, R., Zhang, X., et al. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00675.2023 · Cited by 27
Alveolar macrophages: guardians of the alveolar lipid galaxy
Little, I., Bersie, S. M., Redente, E. F., McCubbrey, A. L., & Tarling, E. J. (2025) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000987 · Cited by 27
“2) [59,60].”
Matrix metalloproteinase activity in the lung is increased in Hermansky-Pudlak syndrome
Summer, R. S., Krishna, R., Schriner, D., Cuevas-Mora, K., Sales, D., Para, R., Roman, J., Nieweld, C., Gochuico, B. R., & Romero, F. (2019) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-019-1143-0 · Cited by 23
Huang, M., Smith, A., Watson, M. C., Bhandari, R., Baugh, L. M., Ivanovska, I. L., Watkins, T., Lang, I. M., Trojanowska, M., Black, L. D., et al. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42097 · Cited by 23
“Subsets of profibrotic macrophages persist in tissue in SSc and induce prolonged fibroblast activation and chronic tissue inflammation, culminating in fibrosis (24,43).”
BackgroundInsights from Transcriptomics: CD163+ Profibrotic Lung Macrophages in COVID-19
Bhattacharya, M. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2022-0107tr · Cited by 26
Tavares, L. P., Brüggemann, T. R., Rezende, R. M., Machado, M. G., Cagnina, R. E., Shay, A. E., Garcia, C. C., Nijmeh, J., Teixeira, M. M., & Levy, B. D. (2022) · mBio · doi:10.1128/mbio.01267-22 · Cited by 24
“microenvironmental factors to express similar markers of the embryonically seeded rAMs (32, 40); however, some transcriptional and functional differences persist in a now hetero-”
BackgroundCai, Z., Tian, Y., Li, J.-Z., Zhao, P., Li, J., Mei, X., & Bai, Y. (2022) · Bioscience Reports · doi:10.1042/bsr20220986 · Cited by 25
Molecular imaging of chemokine-like receptor 1 (CMKLR1) in experimental acute lung injury
Mannes, P. Z., Barnes, C. E., Biermann, J., Latoche, J. D., Day, K. E., Zhu, Q., Tabary, M., Xiong, Z., Nedrow, J. R., Izar, B., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2216458120 · Cited by 29
“…macrophages which have acquired a close transcriptional resemblance to tissue-resident alveolar macrophages after an extended period of residence in the lungs, as reported in mice (60), and/or embryonically-derived alveolar macrophages which are induced to express CMKLR1 upon lung inflammation.”
Zhang, T., Zhang, M., Yang, L., Gao, L., & Sun, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1032355 · Cited by 24
“All the steps are the premise of pulmonary fibrosis (70).”
BackgroundHou, F., Wang, H., Zheng, K., Yang, W., Xiao, K., Rong, Z., Xiao, J., Li, J., Cheng, B., Tang, L., et al. (2023) · Immune Network · doi:10.4110/in.2023.23.e24 · Cited by 24
“However, the long-term existence of pMDMs may contribute to fibrosis (34).”
BackgroundXuan, L., Ren, L., Zhang, W., Du, P., Li, B., & An, Z. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.168947 · Cited by 24
Myeloid TBK1 Signaling Contributes to the Immune Response to Influenza
Hagan, R. S., Torres-Castillo, J. L., & Doerschuk, C. M. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0122oc · Cited by 27
Non-genetic Heterogeneity of Macrophages in Diseases—A Medical Perspective
Gessain, G., Blériot, C., & Ginhoux, F. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.613116 · Cited by 25
“These results revealed remarkable heterogeneity in AM functions according to their origin with important repercussions for the design of innovative myeloid-targeted therapy against fibrosis (Misharin et al., 2017).”
BackgroundImmunopathogenesis of Primary Graft Dysfunction After Lung Transplantation
Bharat, A., & Kreisel, D. (2018) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2017.11.007 · Cited by 23
Self-citationPham, T. H. M., & Monack, D. M. (2023) · Current Opinion in Immunology · doi:10.1016/j.coi.2023.102367 · Cited by 22
Lung macrophages: current understanding of their roles in Ozone-induced lung diseases
Patial, S., & Saini, Y. (2020) · Critical Reviews in Toxicology · doi:10.1080/10408444.2020.1762537 · Cited by 26
“Misharin et al. (2017) reported that monocyte-derived macrophages are recruited during various lung fibrotic stages, and that expression of caspase-8, a cysteine protease, on these macrophages contributes to the worsening of lung pathology.”
BackgroundMizutani, S., Nishio, J., Kondo, K., Motomura, K., Yamada, Z., Masuoka, S., Yamada, S., Muraoka, S., Ishii, N., Kuboi, Y., et al. (2021) · Pharmaceuticals · doi:10.3390/ph14050474 · Cited by 23
Sutherland, T. E., Shaw, T. N., Lennon, R., Herrick, S. E., & Rückerl, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.715209 · Cited by 25
“essential drivers of the fibrotic pathology and disease progression [27].”
BackgroundLamichhane, R., Patial, S., & Saini, Y. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.116228 · Cited by 26
Verhoeven, D. E. (2018) · Viral Immunology · doi:10.1089/vim.2018.0121 · Cited by 28
“They can be resident, arising during embryogenesis, or inflammatory, arising from monocyte recruitment to the lungs during infection (17,51).”
Do-Umehara, H. C., Chen, C., Zhang, Q., Misharin, A. V., Abdala‐Valencia, H., Casalino‐Matsuda, S. M., Reyfman, P. A., Anekalla, K. R., González-González, F. J., Sala, M. A., et al. (2020) · Science Advances · doi:10.1126/sciadv.abb7238 · Cited by 24
Self-citationIliakis, C. S., Kulikauskaite, J., Aegerter, H., Li, F., Piattini, F., Jakubzick, C., Guilliams, M., Köpf, M., & Wack, A. (2023) · Nature Immunology · doi:10.1038/s41590-023-01602-1 · Cited by 23
β-Glucan reprograms alveolar macrophages via neutrophil/IFNγ axis in a murine model of lung injury
Prével, R., Pernet, E., Tran, K. A., Sadek, A., Sadeghi, M., Lapshina, E., Jurado, L. F., Kristof, A. S., Moumni, M., Poschmann, J., et al. (2024) · eLife · doi:10.7554/elife.102068 · Cited by 29
“The pulmonary AM pool can also be replenished beyond the neonatal period by bone marrow-derived monocytes following different stimuli ( Misharin et al., 2017 ; Li et al., 2022 ).”
InfluentialIdiiatullina, E., & Parker, D. (2025) · eLife · doi:10.7554/elife.104918 · Cited by 27
“Other phenotypic transitions include pro-fibrotic macrophages contributing to tissue remodeling ( Misharin et al., 2017 ), and inflammatory subsets expressing high levels of TNF and IL-6 ( Hou et al., 2021 ).”
Tarique, A. A., Evron, T., Zhang, G., Tepper, M. A., Morshed, M. M., Andersen, I., Begum, N., Sly, P. D., & Fantino, E. (2020) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2020.03.015 · Cited by 20
CRTH2 Mediates Profibrotic Macrophage Differentiation and Promotes Lung Fibrosis
Cao, Y., Rudrakshala, J., Williams, R., Rodriguez, S., Sorkhdini, P., Yang, A. X., Mundy, M. A., Yang, D., Palmisciano, A. J., Walsh, T. P., et al. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2021-0504oc · Cited by 25
Poole, J. A., Gaurav, R., Schwab, A. D., Nelson, A. J., Gleason, A., Romberger, D. J., & Wyatt, T. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-22346-2 · Cited by 21
Liu, S., Zhang, Z., Wang, Y., Zhang, Y., Min, J., Li, X., & Liu, S. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110343 · Cited by 22
Metadata
- Authors
- Misharin, A. V., Morales-Nebreda, L., Reyfman, P. A., Cuda, C. M., Walter, J. M., McQuattie-Pimentel, A. C., Chen, C.-I., Anekalla, K. R., Joshi, N., Williams, K. J. N., Abdala-Valencia, H., Yacoub, T. J., Chi, M., Chiu, S., Gonzalez-Gonzalez, F. J., Gates, K., Lam, A. P., Nicholson, T. T., Homan, P. J., Soberanes, S., Dominguez, S., Morgan, V. K., Saber, R., Shaffer, A., Hinchcliff, M., Marshall, S. A., Bharat, A., Berdnikovs, S., Bhorade, S. M., Bartom, E. T., Morimoto, R. I., Balch, W. E., Sznajder, J. I., Chandel, N. S., Mutlu, G. M., Jain, M., Gottardi, C. J., Singer, B. D., Ridge, K. M., Bagheri, N., Shilatifard, A., Budinger, G. R. S., & Perlman, H.
- Affiliations
- Northwestern University (US)
- Division of Pulmonary and Critical Care Medicine, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 1
- Division of Rheumatology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 2
- Scripps Research Institute (US)
- University of Chicago (US)
- Corresponding author
- Perlman, Harris
- ORCID
- Misharin, Alexander V.
- Reyfman, Paul A.
- Cuda, Carla M.
- Walter, James M.
- McQuattie-Pimentel, Alexandra C.
- Chen, Ching-I
- Anekalla, Kishore R.
- Joshi, Nikita
- Chiu, Stephen
- Gonzalez-Gonzalez, Francisco J.
- Lam, Anna P.
- Nicholson, Trevor T.
- Homan, Philip J.
- Soberanes, Saul
- Dominguez, Salina
- Morgan, Vince K.
- Saber, Rana
- Shaffer, Alexander
- Hinchcliff, Monique
- Marshall, Stacy A.
- Bharat, Ankit
- Berdnikovs, Sergejs
- Bhorade, Sangeeta M.
- Bartom, Elizabeth T.
- Morimoto, Richard I.
- Balch, William E.
- Sznajder, Jacob I.
- Chandel, Navdeep S.
- Mutlu, Gökhan M.
- Jain, Manu
- Gottardi, Cara J.
- Singer, Benjamin D.
- Ridge, Karen M.
- Bagheri, Neda
- Shilatifard, Ali
- Budinger, G.R. Scott
- Perlman, Harris
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2017-07-10
- Volume
- 214
- Issue
- 8
- Pages
- 2387-2404
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC5551573
- OpenAlex
- W2736034593
- Cited by
- 1,133
- References
- 87
- Citations by year
- 2026: 139 · 2025: 131 · 2024: 156 · 2023: 135 · 2022: 136 · 2021: 128 · 2020: 134 · 2019: 81 · 2018: 77 · 2017: 15
- FWCI
- 68.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- NIH (AR064313, HL128867, T32 DK077662, HL125940, AG049665, HL048129, HL071643, HL085534, ES015024, ES025644, HL079190, HL124664, ES013995, AR064546, HL134375)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR061593)
- Scleroderma Foundation
- Department of Defense (PR141319)
- BD Bioscience
- Northwestern University (5T32 HL076139-13)
- American Society for Transplant Surgery Foundation
- Thoracic Surgery Foundation
- Society of University Surgeons
- American Association of Thoracic Surgery
- Parker B. Francis
- Veterans Administration (BX000201)
- Mabel Greene Myers
- National Cancer Institute (P30 CA060553)
- Feinberg School of Medicine
- American Thoracic Society
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- pulmonary fibrosis, alveolar macrophages, monocyte-derived macrophages, tissue-resident macrophages, monocyte-to-macrophage differentiation, fibrosis resolution, gene deletion, gene expression profiling
- MeSH terms
- Animals, Cell Differentiation, Fibrosis, Humans, Lung, Monocytes, Macrophages, Alveolar, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.